Assignment: Ethical and Legal Implications of Prescribing Drugs

• Review the Resources  and consider the legal and ethical implications of prescribing      prescription drugs, disclosure, and nondisclosure.
• Review the scenario assigned for  this Assignment (below).
• Search specific laws and      standards for prescribing prescription drugs and for addressing medication      errors for your state or region and reflect on these as you review the      scenario assigned.
• Consider the ethical and legal      implications of the scenario for all stakeholders involved, such as the      prescriber, pharmacist, patient, and patient’s family.
• Think about two strategies an      advanced practice nurse, would use to guide your ethically and legally      responsible decision-making in this scenario, including whether you would      disclose any medication errors.

Write a 3-page paper that addresses the following:

• Explain the ethical and legal  implications of the scenario selected on all stakeholders involved, such      as the prescriber, pharmacist, patient, and patient’s family.
• Describe strategies to address      disclosure and nondisclosure as identified in the scenario you selected.      Be sure to reference laws specific to your state.
• Explain two strategies that      you, as an advanced practice nurse, would use to guide your decision      making in this scenario, including whether you would disclose your error.      Be sure to justify your explanation.
• Explain the process of writing prescriptions, including      strategies to minimize medication errors.

Assigned scenario:

A friend calls and asks you to prescribe a medication for her. You have this autonomy, but you don’t have your friend’s medical history. You write the prescription anyway.

Resources:

Rosenthal, L. D., & Burchum, J. R. (2018). Lehne’s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.

• Chapter 1, “Prescriptive      Authority” (pp. 1–3)
• Chapter 2, “Rational Drug      Selection and Prescription Writing” (pp. 5–9)
• Chapter 3, “Promoting Positive      Outcomes of Drug Therapy” (pp. 11–16)
• Chapter 4, “Pharmacokinetics,      Pharmacodynamics, and Drug Interactions” (pp. 17–40)
• Chapter 5, “Adverse Drug      Reactions and Medical Errors” (pp. 41–49)
• Chapter 6, “Individual      Variation in Drug Response” (pp. 51–56)

https://www.deadiversion.usdoj.gov/21cfr/cfr/1300/1300_01.htm

http://www.deadiversion.usdoj.gov/drugreg/practioners/index.html